The first commercial test for Zika virus has received emergency use authorization by the U.S. Food and Drug Administration.

According to the test's developers, Quest Diagnostics, the newly approved diagnostic tool will become available to physicians in the United States and Puerto Rico as early as next week.

Puerto Rico is considered to be among the most affected areas, compared to the rest of the United States, with potential for hundreds more infections.

Zika virus definitely causes birth defects, CDC says CDC: Zika virus causes birth defects, microcephaly The CDC recommends testing for anyone with symptoms of Zika infection who has traveled to an area with transmission within the past two weeks, as well as any pregnant women who have lived or visited affected regions.

How the test works The commercial test uses a process known as real-time RT-PCR to test for the presence of Zika virus in blood samples.